4.4 Article

Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a CoIII-Ebox Conjugate

Journal

CHEMBIOCHEM
Volume 16, Issue 14, Pages 2065-2072

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201500289

Keywords

cancer; cobalt; metastasis; Snail; transcription factor

Funding

  1. National Cancer Institute [RO3A167715]
  2. National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) [P30AR057216]
  3. National Science Foundation [CHE-9810378/005]
  4. National Institutes of Health Centers of Cancer Nanotechnology Excellence initiative of the National Cancer Institute [U54A119341]

Ask authors/readers for more resources

The transition from a non-invasive to an invasive phenotype is an essential step in tumor metastasis. The Snail family of transcription factors (TFs) is known to play a significant role in this transition. These TFs are zinc fingers that bind to the CAGGTG Ebox consensus sequence. Co-III-Ebox is a cobalt(III) complex attached to an Ebox oligonucleotide that confers specificity towards Snail TFs. CoIII-Ebox has been shown to inhibit Snailmediated embryonic neural crest development in Xenopus laevis, but its efficacy in inhibiting Snail-induced cancer cell invasiveness has not been explored. Here, we describe the efficacy of Co-III-Ebox in inhibiting the invasive aspects of heregulin-beta 1(HRG)-treated breast cancer cells. Co-III-Ebox was found to inhibit the capacity of Snail to repress target genes after HRG induction. Snail inhibition by Co-III-Ebox reduced the invasive propensity of cells in 2D and 3D, thereby demonstrating promise in inhibiting metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available